<VariationArchive VariationID="695094" VariationName="NM_198503.5(KCNT2):c.143_144del (p.Leu48fs)" VariationType="Deletion" Accession="VCV000695094" Version="3" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-23" DateCreated="2019-12-16" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="683211" VariationID="695094">
      <GeneList>
        <Gene Symbol="KCNT2" FullName="potassium sodium-activated channel subfamily T member 2" GeneID="343450" HGNC_ID="HGNC:18866" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="196225779" stop="196608440" display_start="196225779" display_stop="196608440" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NW_025791754.1" start="75455" stop="458104" display_start="75455" display_stop="458104" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="196194912" stop="196577498" display_start="196194912" display_stop="196577498" Strand="-" />
          </Location>
          <OMIM>610044</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_198503.5(KCNT2):c.143_144del (p.Leu48fs)</Name>
      <CanonicalSPDI>NC_000001.11:196492292:TA:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q31.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="196492293" stop="196492294" display_start="196492293" display_stop="196492294" variantLength="2" positionVCF="196492292" referenceAlleleVCF="TTA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="196461423" stop="196461424" display_start="196461423" display_stop="196461424" variantLength="2" positionVCF="196461422" referenceAlleleVCF="TTA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>L48fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.196461423_196461424del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.196461423_196461424del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.196492293_196492294del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.196492293_196492294del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287819.3" sequenceAccession="NM_001287819" sequenceVersion="3" change="c.143_144del">
            <Expression>NM_001287819.3:c.143_144del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274748.1" sequenceAccession="NP_001274748" sequenceVersion="1" change="p.Leu48fs">
            <Expression>NP_001274748.1:p.Leu48fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287820.3" sequenceAccession="NM_001287820" sequenceVersion="3" change="c.143_144del">
            <Expression>NM_001287820.3:c.143_144del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274749.1" sequenceAccession="NP_001274749" sequenceVersion="1" change="p.Leu48fs">
            <Expression>NP_001274749.1:p.Leu48fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198503.5" sequenceAccession="NM_198503" sequenceVersion="5" change="c.143_144del" MANESelect="true">
            <Expression>NM_198503.5:c.143_144del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_940905.2" sequenceAccession="NP_940905" sequenceVersion="2" change="p.Leu48fs">
            <Expression>NP_940905.2:p.Leu48fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_146057.2" sequenceAccession="NR_146057" sequenceVersion="2" change="n.274_275del">
            <Expression>NR_146057.2:n.274_275del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_146058.2" sequenceAccession="NR_146058" sequenceVersion="2" change="n.274_275del">
            <Expression>NR_146058.2:n.274_275del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1572630269" DB="dbSNP" />
        <XRef Type="Allelic variant" ID="610044.0005" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_198503.5(KCNT2):c.143_144del (p.Leu48fs) AND Seizure" Accession="RCV000857310" Version="1">
        <ClassifiedConditionList TraitSetID="8220">
          <ClassifiedCondition DB="MedGen" ID="C0036572">Seizure</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-11-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_198503.5(KCNT2):c.143_144del (p.Leu48fs) AND Developmental and epileptic encephalopathy, 57" Accession="RCV001269350" Version="2">
        <ClassifiedConditionList TraitSetID="39669">
          <ClassifiedCondition DB="MedGen" ID="C4540411">Developmental and epileptic encephalopathy, 57</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-11-11" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2019-12-16" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">32038177</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8220" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="17066" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Seizure</ElementValue>
                <XRef ID="HP:0001250" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Seizures</ElementValue>
                <XRef ID="Seizures/6489" DB="Genetic Alliance" />
                <XRef ID="HP:0001250" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C0036572" DB="MedGen" />
              <XRef Type="primary" ID="HP:0001250" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001275" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001303" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002125" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002182" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002279" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002306" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002348" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002391" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002417" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002430" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002431" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002432" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002434" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002437" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002466" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002479" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0002794" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006997" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0010520" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="39669" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38351" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 57</ElementValue>
                <XRef ID="MONDO:0033366" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57</ElementValue>
                <XRef Type="MIM" ID="617771" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DEE57</ElementValue>
                <XRef Type="MIM" ID="617771" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EIEE57</ElementValue>
                <XRef Type="MIM" ID="617771" DB="OMIM" />
              </Symbol>
              <XRef ID="C4540411" DB="MedGen" />
              <XRef ID="MONDO:0033366" DB="MONDO" />
              <XRef Type="MIM" ID="617771" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1964689" SubmissionDate="2019-11-30" DateLastUpdated="2019-12-16" DateCreated="2019-12-16">
        <ClinVarSubmissionID localKey="SUB6626079" submittedAssembly="GRCh37" title="SUB6626079" />
        <ClinVarAccession Accession="SCV000999383" DateUpdated="2019-12-16" DateCreated="2019-12-16" Type="SCV" Version="1" SubmitterName="Department of Medical Genetics, Hunan Provincial Maternal and Child Health Care Hospital" OrgID="507311" OrganizationCategory="clinic" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant showed dominant negative effect in our vitro study</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Sporadic</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">20</Age>
              <Age Type="maximum" age_unit="years">29</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNT2">
              <Name>potassium sodium-activated channel subfamily T member 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198503.2:c.143_144delTA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="HP" ID="HP:0001250" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6626079</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2860614" SubmissionDate="2020-12-04" DateLastUpdated="2020-12-07" DateCreated="2020-12-07">
        <ClinVarSubmissionID localKey="610044.0005_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 57" title="KCNT2, 2-BP DEL, 143TA_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 57" />
        <ClinVarAccession Accession="SCV001448720" DateUpdated="2020-12-07" DateCreated="2020-12-07" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-04">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 29-year-old Chinese woman (patient B) with developmental and epileptic encephalopathy-57 (DEE57; 617771), Mao et al. (2020) identified a de novo heterozygous 2-bp deletion (c.143_144delTA, NM_198503.2) in the KCNT2 gene, resulting in a frameshift and premature termination (Leu48GlnfsTer43) in the N-terminal domain. The mutation, which was found by exome sequencing and confirmed by Sanger sequencing, was not present in multiple control databases, including dbSNP and gnomAD. In vitro electrophysiologic studies in CHO cells showed that heteromeric channels expressing the mutation resulted in decreased potassium currents by about 55% compared to controls; there was some evidence of a dominant-negative effect. The patient had onset of multifocal seizures at 4 months of age.</Attribute>
              <Citation>
                <ID Source="PubMed">32038177</ID>
              </Citation>
              <XRef DB="OMIM" ID="617771" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNT2" />
          </GeneList>
          <Name>KCNT2, 2-BP DEL, 143TA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 143TA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610044.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 57</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9851461" SubmissionDate="2024-06-20" DateLastUpdated="2024-07-15" DateCreated="2024-07-15">
        <ClinVarSubmissionID localKey="30303615488_3" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005073932" DateUpdated="2024-07-15" DateCreated="2024-07-15" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The observed frameshift variant c.143_144del (p.Leu48GlnfsTer43) in KCNT2 gene has been reported previously in individuals affected with KCNT2-related epileptic encephalopathy (Mao et al. 2020). In vitro electrophysiologic studies in hinese hamster ovarian (CHO) cells showed that heteromeric channels expressing the mutation resulted in decreased potassium currents by about 55% compared to controls; with a potential dominant-negative effect (Mao et al. 2020). The p.Leu48GlnfsTer43 variant is absent in gnomAD Exomes database. This variant has been submitted to the ClinVar database as Pathogenic. This variant causes a frameshift starting with codon Leucine 48, changes this amino acid to Glutamine residue, and creates a premature Stop codon at position 43 of the new reading frame, denoted p.Leu48GlnfsTer43. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198503.5:c.143_144del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617771" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14550130</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9851461" TraitType="Disease" MappingType="XRef" MappingValue="617771" MappingRef="OMIM">
        <MedGen CUI="C4540411" Name="Developmental and epileptic encephalopathy, 57" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1964689" TraitType="Disease" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2860614" TraitType="Disease" MappingType="Name" MappingValue="DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 57" MappingRef="Preferred">
        <MedGen CUI="C4540411" Name="Developmental and epileptic encephalopathy, 57" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

